Biogipuzkoa Health Research Institute

This study is testing whether adding two substances, EH-301 and N-acetylcysteine (NAC), to the standard ALS drug riluzole can slow down the disease. It will involve 90 people with early-stage ALS who can still walk. Participants will be randomly assigned to get either the real co…